Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zymeworks (ZYME) Capital Expenditures (2021 - 2025)

Zymeworks' Capital Expenditures history spans 5 years, with the latest figure at $581000.0 for Q4 2025.

  • On a quarterly basis, Capital Expenditures rose 134.65% to $581000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $1.5 million, a N/A change, with the full-year FY2025 number at $1.5 million, changed N/A from a year prior.
  • Capital Expenditures hit $581000.0 in Q4 2025 for Zymeworks, up from $410000.0 in the prior quarter.
  • Over the last five years, Capital Expenditures for ZYME hit a ceiling of $6.8 million in Q3 2022 and a floor of -$6.8 million in Q4 2022.
  • Historically, Capital Expenditures has averaged $180250.0 across 5 years, with a median of $398000.0 in 2023.
  • Biggest five-year swings in Capital Expenditures: plummeted 2510.21% in 2022 and later surged 881.74% in 2024.
  • Tracing ZYME's Capital Expenditures over 5 years: stood at $284000.0 in 2021, then plummeted by 2510.21% to -$6.8 million in 2022, then skyrocketed by 86.11% to -$951000.0 in 2023, then plummeted by 76.34% to -$1.7 million in 2024, then soared by 134.65% to $581000.0 in 2025.
  • Business Quant data shows Capital Expenditures for ZYME at $581000.0 in Q4 2025, $410000.0 in Q3 2025, and $449000.0 in Q2 2025.